Neurology devices are specialized surgical devices used for the treatment of disease or conditions of the central nervous system (CNS) and spine. Neuroendoscopes are endoscopes which are used for treatment of conditions of the central nervous system. GlobalData uses proprietary data and analytics to provide a comprehensive report on the neuroendoscopes devices market, including market shares of different players within Switzerland. Buy the latest report here.
Smarter leaders trust GlobalData
In 2021, GlobalData’s Market Model methodology determined that the leading player in the neuroendoscopes market in Switzerland was KARL STORZ SE followed by B. Braun Melsungen and Adeor Medical.
Disposable devices and accessories are not considered in this segment. The Flexible Neuroendoscopes type of endoscope has a flexible tube along with components such as eye piece, lens etc. The Rigid Neuroendoscopes type of endoscope has a rigid tube along with components such as eye piece, lens etc.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the neuroendoscopes devices market within Switzerland was expected to be over $0.6m in 2021.
For the latest complete market share analysis of neuroendoscopes device market in Switzerland, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
